Inactive Instrument

Forest Laboratories, Inc. Stock

Stocks

End-of-day quote NYSE
- ^USD	-

06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE

06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE
14/04/14	Actavis : Investors support deals spree, happy to see U.S. companies buy growth	RE
11/04/14	Icahn backs down from demand that eBay spin off PayPal	RE
21/02/14	Suntory Beverage & Food Ltd : Goldman Sachs misses out on WhatsApp, 2014's top deals so far	RE
19/02/14	Icahn says Actavis-Forest deal validates shareholder activism	RE
19/02/14	Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/02/14	Actavis PLC : Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/02/14	Actavis PLC : Actavis in talks to buy Forest Labs for as much as $25 billion - WSJ	RE
09/01/14	S&P 500 ends flat in wake of Fed minutes	RE
08/01/14	Forest Laboratories, Inc. : Forest Labs to buy Aptalis from TPG for $2.9 billion	RE
08/01/14	Evercore Partners Inc. : Forest Labs nears $3 billion deal for Aptalis - source	RE
24/10/13	Elan Corporation, plc : Exclusive - TPG-backed Aptalis Pharma hires banks for an IPO: sources	RE

01/07/14	Forest Laboratories : Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest	BU
30/06/14	Forest Laboratories : Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results	BU
24/06/14	Forest Laboratories : Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD)	BU
23/06/14	Forest Laboratories : Actavis and Forest Laboratories Announce Appointment of C. David Nicholson, PhD to lead Actavis Global Brands Research and Development	BU
21/06/14	Forest Laboratories : to Present Cariprazine Data at the International College of Neuropsychopharmacology World Congress	BU

17/11/16	Devisen: Euro fällt zum USD weiter - Hinweise auf US-Zinserhöhung belasten
28/04/14	Bank of America : Wall Street ouvre en hausse, les pharmaceutiques en vue
28/04/14	Wall Street ouvre en hausse, les pharmaceutiques en vue
28/04/14	Actavis : Forest Laboratories achète Furiex pour 1,46 milliard de dollars
28/04/14	Forest Laboratories : Pharmacie-Forest achète Furiex pour $1,46 milliard